Waters Co. (NYSE:WAT) Holdings Decreased by Kintegral Advisory LLC

Kintegral Advisory LLC cut its position in shares of Waters Co. (NYSE:WAT) by 4.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 7,670 shares of the medical instruments supplier’s stock after selling 357 shares during the period. Kintegral Advisory LLC’s holdings in Waters were worth $2,845,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in WAT. Advisory Alpha LLC lifted its stake in shares of Waters by 2.6% in the 4th quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier’s stock worth $395,000 after acquiring an additional 27 shares during the period. Summit Trail Advisors LLC raised its holdings in Waters by 2.4% during the third quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier’s stock worth $431,000 after purchasing an additional 28 shares in the last quarter. Empowered Funds LLC lifted its position in Waters by 3.0% in the fourth quarter. Empowered Funds LLC now owns 966 shares of the medical instruments supplier’s stock worth $358,000 after purchasing an additional 28 shares during the period. Deroy & Devereaux Private Investment Counsel Inc. boosted its stake in Waters by 0.3% during the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier’s stock valued at $3,565,000 after purchasing an additional 30 shares in the last quarter. Finally, OneDigital Investment Advisors LLC increased its position in shares of Waters by 3.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock valued at $306,000 after purchasing an additional 31 shares during the period. 94.01% of the stock is currently owned by institutional investors.

Waters Trading Down 1.7 %

NYSE WAT opened at $374.24 on Friday. The firm’s 50 day moving average price is $388.85 and its two-hundred day moving average price is $365.60. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56. The stock has a market cap of $22.22 billion, a price-to-earnings ratio of 34.94, a PEG ratio of 3.79 and a beta of 1.01.

Waters (NYSE:WAT) last issued its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Equities analysts anticipate that Waters Co. will post 12.86 EPS for the current year.

Wall Street Analyst Weigh In

WAT has been the subject of several research analyst reports. JPMorgan Chase & Co. upped their price objective on Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Wells Fargo & Company boosted their price target on shares of Waters from $415.00 to $420.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Sanford C. Bernstein upgraded shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price objective for the company in a research report on Friday, January 10th. StockNews.com upgraded shares of Waters from a “hold” rating to a “buy” rating in a report on Monday, February 17th. Finally, Bank of America reduced their target price on shares of Waters from $430.00 to $410.00 and set a “neutral” rating for the company in a report on Thursday, February 13th. Ten research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Waters has an average rating of “Hold” and a consensus price target of $390.40.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.